Effect of Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients

Clinical trial NCT02274740 · TERMINATED

Trial details

NCT number: NCT02274740
Sponsor: Sanofi
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Type II Diabetes Mellitus

Start date: 2015-04-01
Primary completion: 2015-08-01
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.